|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| Marketable securities held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT | ||||||||
| Current liabilities | ||||||||
| Accounts Payable | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Due to Sponsor, net | ||||||||
| Promissory note - related party | ||||||||
| Accrued offering costs | ||||||||
| Total Current Liabilities | ||||||||
| Subscription Agreement liability | ||||||||
| Deferred underwriting fee | ||||||||
| TOTAL LIABILITIES | ||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 14,651,303 and 17,250,000 shares issued and outstanding at redemption value of $10.87 and $10.53 per share as of September 30, 2026 and December 31, 2025, respectively | ||||||||
| SHAREHOLDERS' DEFICIT | ||||||||
| Common stock | ||||||||
| Class A ordinary shares not subject to redemption | ||||||||
| Class B | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders' Deficit | ||||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT |
Loading...